Information updates

COVID-19 Vaccination Update

COVID-19 vaccination is an important way to reduce the risk of developing COVID-19, which is caused by infection with the SARS-CoV-2 coronavirus. Even if a person does get infected, it is likely to be a milder illness if they have been vaccinated.

Once there is a very high level of COVID-19 vaccination in the population, this can allow travel, work, schools, social activities and in person retail shopping to resume.

From an allergy perspective the only contraindication to COVID-19 vaccination is documented anaphylaxis to a previous COVID-19 vaccine or documented anaphylaxis to one of the components (excipients) contained in COVID-19 vaccines. There is limited use for skin testing to COVID vaccines and their excipients.

Anaphylaxis to vaccines is rare, and almost always occurs within 30 minutes of vaccination. Most people who have anaphylaxis to one type of COVID-19 vaccine will be able to have one of the other types of COVID-19 vaccines.

The seriousness of the COVID-19 pandemic and health consequences mean that medical exemptions under the 'other specified medical condition' category are generally not issued. 

Clinical immunology/allergy specialists are strong advocates for vaccination.  Due to current waiting times of at least six months for appointments to see clinical immunology/allergy specialists, discussions about the numerous benefits and rare risks of COVID-19 vaccination may delay timely vaccination, and people seeking medical exemptions should be aware of the health consequences.

Further information is available from the ASCIA website

https://www.allergy.org.au/patients/covid-19

 

 

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.